PDLIM1 Antibody (CPTC-PDLIM1-1) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08842F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # CPTC-PDLIM1-1
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human full-length PDLIM1 protein (Uniprot: O00151)
Localization
Cytoplasm
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for PDLIM1 Antibody (CPTC-PDLIM1-1) [FITC]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PDLIM1
Alternate Names
CLIM1carboxyl terminal LIM domain protein 1, CLP-36, CLP36carboxy terminal LIM domain protein 1, C-terminal LIM domain protein 1, elfin, enigma, hCLIM1, LIM domain protein CLP-36, PDZ and LIM domain 1, PDZ and LIM domain 1 (elfin), PDZ and LIM domain protein 1
Gene Symbol
PDLIM1
Additional PDLIM1 Products
Product Documents for PDLIM1 Antibody (CPTC-PDLIM1-1) [FITC]
Product Specific Notices for PDLIM1 Antibody (CPTC-PDLIM1-1) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...